https://www.statcounter.com/counter/counter.js
Web Analytics
Home » 2016 » October
Martindale Pharma's clobazam oral suspension for Epilepsy approved

Martindale Pharma's clobazam oral suspension for Epilepsy approved

UK based Martindale Pharma has secured a regulatory approval of its clobazam oral suspension medicine in seven European countries. Branded as Epaclob, the global pharma company’s clobazam oral suspension has been approved in France, Iraland, Germany and Italy. In Denmark, Spain and Iceland, the same clobazam oral suspension which is branded as Silocalm, has also […]

Asthma research leads to Gaucher's Disease treatment approach

A new treatment was discovered unexpectedly for Gaucher’s Disease, an inherited enzyme disease, while carrying out a regular research on asthma at the NYU Langone Medical Center based in New York City. The researchers were conducting experiments to study the action of proteins in protecting lungs from asthma related damage. Inherited Enzyme Disease, also known […]

Continue reading …
Breast Cancer Cognitive Impairment : Belgium University to conduct ground-breaking clinical trial

Belgium-based The University of Antwerp is all set to conduct its first clinical trial to reduce the severity of the cognitive deficit associated with breast cancer treatment. For this, the University of Antwerp will be using a video game training and assessment, scientifically-designed by UK-based My Cognition which focuses on cognitive health. Breast Cancer Cognitive […]

Continue reading …
Sun Pharma to develop dengue vaccine in collaboration with ICGEB

Indian multinational pharmaceutical company Sun Pharma is collaborating with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop dengue vaccine at an affordable cost for global markets. The new dengue vaccine would be safer and more effective than the existing vaccine as per the manufacturer. It targets all the four serotypes of dengue viruses […]

Continue reading …